Literature DB >> 28302723

Identification and characterization of a missense mutation in the O-linked β-N-acetylglucosamine (O-GlcNAc) transferase gene that segregates with X-linked intellectual disability.

Krithika Vaidyanathan1, Tejasvi Niranjan2, Nithya Selvan1, Chin Fen Teo1, Melanie May3, Sneha Patel1, Brent Weatherly1, Cindy Skinner3, John Opitz4, John Carey4, David Viskochil4, Jozef Gecz5, Marie Shaw5, Yunhui Peng6, Emil Alexov6, Tao Wang2, Charles Schwartz7, Lance Wells8.   

Abstract

O-GlcNAc is a regulatory post-translational modification of nucleocytoplasmic proteins that has been implicated in multiple biological processes, including transcription. In humans, single genes encode enzymes for its attachment (O-GlcNAc transferase (OGT)) and removal (O-GlcNAcase (OGA)). An X-chromosome exome screen identified a missense mutation, which encodes an amino acid in the tetratricopeptide repeat, in OGT (759G>T (p.L254F)) that segregates with X-linked intellectual disability (XLID) in an affected family. A decrease in steady-state OGT protein levels was observed in isolated lymphoblastoid cell lines from affected individuals, consistent with molecular modeling experiments. Recombinant expression of L254F-OGT demonstrated that the enzyme is active as both a glycosyltransferase and an HCF-1 protease. Despite the reduction in OGT levels seen in the L254F-OGT individual cells, we observed that steady-state global O-GlcNAc levels remained grossly unaltered. Surprisingly, lymphoblastoids from affected individuals displayed a marked decrease in steady-state OGA protein and mRNA levels. We observed an enrichment of the OGT-containing transcriptional repressor complex mSin3A-HDAC1 at the proximal promoter region of OGA and correspondingly decreased OGA promoter activity in affected cells. Global transcriptome analysis of L254F-OGT lymphoblastoids compared with controls revealed a small subset of genes that are differentially expressed. Thus, we have begun to unravel the molecular consequences of the 759G>T (p.L254F) mutation in OGT that uncovered a compensation mechanism, albeit imperfect, given the phenotype of affected individuals, to maintain steady-state O-GlcNAc levels. Thus, a single amino acid substitution in the regulatory domain (the tetratricopeptide repeat domain) of OGT, which catalyzes the O-GlcNAc post-translational modification of nuclear and cytosolic proteins, appears causal for XLID.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28302723      PMCID: PMC5448127          DOI: 10.1074/jbc.M116.771030

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

Review 1.  The emerging significance of O-GlcNAc in cellular regulation.

Authors:  Natasha E Zachara; Gerald W Hart
Journal:  Chem Rev       Date:  2002-02       Impact factor: 60.622

Review 2.  The epidemiology of mental retardation: challenges and opportunities in the new millennium.

Authors:  Helen Leonard; Xingyan Wen
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

Review 3.  Nucleoplasmic and cytoplasmic glycoproteins.

Authors:  G W Hart; R S Haltiwanger; G D Holt; W G Kelly
Journal:  Ciba Found Symp       Date:  1989

4.  The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny.

Authors:  R Shafi; S P Iyer; L G Ellies; N O'Donnell; K W Marek; D Chui; G W Hart; J D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

5.  Epigenetic regulation of polymerase II transcription initiation in Trypanosoma cruzi: modulation of nucleosome abundance, histone modification, and polymerase occupancy by O-linked thymine DNA glucosylation.

Authors:  Dilrukshi Ekanayake; Robert Sabatini
Journal:  Eukaryot Cell       Date:  2011-09-16

6.  Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.

Authors:  Y Gao; L Wells; F I Comer; G J Parker; G W Hart
Journal:  J Biol Chem       Date:  2001-01-08       Impact factor: 5.157

7.  Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol.

Authors:  D L Dong; G W Hart
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

Review 8.  'Mental retardation' or 'intellectual disability': time for a conceptual change.

Authors:  Luis Salvador-Carulla; Marco Bertelli
Journal:  Psychopathology       Date:  2007-10-18       Impact factor: 1.944

9.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

Authors:  A P Monaco; R L Neve; C Colletti-Feener; C J Bertelson; D M Kurnit; L M Kunkel
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

10.  The Early Metazoan Trichoplax adhaerens Possesses a Functional O-GlcNAc System.

Authors:  Nithya Selvan; Daniel Mariappa; Henk W P van den Toorn; Albert J R Heck; Andrew T Ferenbach; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2015-03-16       Impact factor: 5.157

View more
  41 in total

Review 1.  Nutrient regulation of signaling and transcription.

Authors:  Gerald W Hart
Journal:  J Biol Chem       Date:  2019-01-09       Impact factor: 5.157

2.  Novel exon-skipping variant disrupting the basic domain of HCFC1 causes intellectual disability without metabolic abnormalities in both male and female patients.

Authors:  Parith Wongkittichote; Daniel J Wegner; Marwan S Shinawi
Journal:  J Hum Genet       Date:  2021-01-30       Impact factor: 3.172

Review 3.  Chemical and Biochemical Strategies To Explore the Substrate Recognition of O-GlcNAc-Cycling Enzymes.

Authors:  Chia-Wei Hu; Matthew Worth; Hao Li; Jiaoyang Jiang
Journal:  Chembiochem       Date:  2018-11-12       Impact factor: 3.164

Review 4.  O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle.

Authors:  John A Hanover; Weiping Chen; Michelle R Bond
Journal:  J Bioenerg Biomembr       Date:  2018-03-29       Impact factor: 2.945

5.  A complex containing the O-GlcNAc transferase OGT-1 and the ubiquitin ligase EEL-1 regulates GABA neuron function.

Authors:  Andrew C Giles; Muriel Desbois; Karla J Opperman; Rubens Tavora; Marissa J Maroni; Brock Grill
Journal:  J Biol Chem       Date:  2019-03-11       Impact factor: 5.157

Review 6.  Critical observations that shaped our understanding of the function(s) of intracellular glycosylation (O-GlcNAc).

Authors:  Natasha E Zachara
Journal:  FEBS Lett       Date:  2018-11-24       Impact factor: 4.124

Review 7.  Nutrient-driven O-GlcNAc in proteostasis and neurodegeneration.

Authors:  Ilhan Akan; Stephanie Olivier-Van Stichelen; Michelle R Bond; John A Hanover
Journal:  J Neurochem       Date:  2017-11-20       Impact factor: 5.372

8.  Aspartate Residues Far from the Active Site Drive O-GlcNAc Transferase Substrate Selection.

Authors:  Cassandra M Joiner; Zebulon G Levine; Chanat Aonbangkhen; Christina M Woo; Suzanne Walker
Journal:  J Am Chem Soc       Date:  2019-08-07       Impact factor: 15.419

9.  O-GlcNAc transferase missense mutations linked to X-linked intellectual disability deregulate genes involved in cell fate determination and signaling.

Authors:  Nithya Selvan; Stephan George; Fatema J Serajee; Marie Shaw; Lynne Hobson; Vera Kalscheuer; Nripesh Prasad; Shawn E Levy; Juliet Taylor; Salim Aftimos; Charles E Schwartz; Ahm M Huq; Jozef Gecz; Lance Wells
Journal:  J Biol Chem       Date:  2018-05-16       Impact factor: 5.157

Review 10.  Molecular Interrogation to Crack the Case of O-GlcNAc.

Authors:  Arielis Estevez; Dongsheng Zhu; Connor Blankenship; Jiaoyang Jiang
Journal:  Chemistry       Date:  2020-07-20       Impact factor: 5.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.